ContractConsulting Agreement • December 18th, 2015 • Cantabio Pharmaceuticals Inc. • Services-management services • New York
ContractCantabio Pharmaceuticals Inc. • December 18th, 2015 • Services-management services
THIS INSTRUMENT AND ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM.
ContractLoan Agreement • December 18th, 2015 • Cantabio Pharmaceuticals Inc. • Services-management services
LOAN AGREEMENT (“The Agreement”) As of the 8th of September 2015Loan Agreement • December 18th, 2015 • Cantabio Pharmaceuticals Inc. • Services-management services
The borrower has requested a loan from the Lender for working capital purposes and the Lender has agreed to grant such loan.
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • December 18th, 2015 • Cantabio Pharmaceuticals Inc. • Services-management services • Delaware
This Agreement and Plan of Merger (the "Agreement") is made as of this 17th day of December 2015 by and among (i) Cantabio Pharmaceuticals Inc., a Delaware corporation (the "Company"), (ii) Cantabio Acquisition Inc., a Delaware corporation ("Merger Sub"), (iii) Gardedam Therapeutics, Inc., a Delaware corporation ("Gardedam"), (iv) Dr. Gergely Toth, (v) Dr. Thomas Roger Sawyer and (vi) Simon Peace (each a “Party” and together the “Parties”).
AgreementCantabio Pharmaceuticals Inc. • December 18th, 2015 • Services-management services
NovAliX Deutschland GmbH (“NOVALIX”), a German corporation located at Seckenheimer Landstrasse 4, D-68163 Mannheim, Germany, represented by its Geschäftsführer, Mr Stephan JENN. The (“COMPANY”), Gardedam Therapeutics, Inc. (“GARDEDAM”), headquartered at 1597 Cross Way San Jose, CA 95125 USA, and any acquiring, merging or successor companies, represented by its CEO, Dr. Gergely TOTH, the (“FOUNDER”),
LOAN AGREEMENTLoan Agreement • December 18th, 2015 • Cantabio Pharmaceuticals Inc. • Services-management services • Delaware
For value received, the undersigned Lion Consulting Group Inc. (the "Borrower"), promises to pay to the order of Capro Ltd (the "Lender"), the sum of $2500.00 with no interest.
ContractInvestment Agreement • December 18th, 2015 • Cantabio Pharmaceuticals Inc. • Services-management services
